Ribas, A. Chesney, J. Long, G. V. Kirkwood, J. M. and Dummer, R. Puzanov, I. Hoeller, C. Gajewski, T. F. and Gutzmer, R. Rutkowski, P. Demidov, L. Arenberger, P. and Shin, S. J. Ferrucci, P. F. Diede, S. J. Anderson, J. R. and Treichel, S. Chan, E. Hodi, F. S. Gogas, H. J., MASTERKEY-265: A phase III, randomized, placebo (Pbo)-controlled study
of talimogene laherparepvec (T) plus pembrolizumab (P) for unresectable
stage IIIB-IVM1c melanoma (MEL), Annals of Oncology, (32), S868-S869, 2021, Elsevier, 0923-7534, 1569-8041